🇺🇸 PARITAPREVIR in United States

970 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Renal Impairment — 164 reports (16.91%)
  2. Drug Interaction — 148 reports (15.26%)
  3. Anaemia — 127 reports (13.09%)
  4. Fatigue — 96 reports (9.9%)
  5. Hyperbilirubinaemia — 88 reports (9.07%)
  6. Hepatic Failure — 81 reports (8.35%)
  7. Nausea — 76 reports (7.84%)
  8. Headache — 69 reports (7.11%)
  9. Pruritus — 65 reports (6.7%)
  10. Hepatocellular Carcinoma — 56 reports (5.77%)

Source database →

PARITAPREVIR in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PARITAPREVIR approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PARITAPREVIR in United States?

Marketing authorisation holder not available in our data.